The Global Health Science and Practice Technical Exchange (GHTechX) took place virtually from April 21 - 24, 2021. The event is curated through a partnership between USAID, the George Washington University, and the Global Health: Science and Practice Journal. Our goal is to convene speakers and technical sessions that highlight the latest and greatest in global health, with participants spanning global health experts, students, and professionals from across the global health community.
Cet évènement s’inscrit dans le cadre d’une série de webinaires de renforcement des capacités visant à améliorer les compétences nationales en matière de chaîne d’approvisionnement des programmes de MTN et à créer un espace de partage d’expérience entre pays.
Les effets indésirables (EI) particulièrement les effets indésirables graves (EIG) associés à l’administration de médicaments de masse ont un impact grave non seulement sur les personnes directement touchées, mais aussi sur la viabilité du programme national de lutte contre les maladies tropicales négligées (MTN) du ministère de la Santé.
Adverse events (AEs) particularly severe adverse events (SAEs) during and following mass drug administration have a serious effect not only on the people who are affected directly, but also on the viability of the MOH’s national NTD control program.
The United States Agency for International Development (USAID) granted funding to FHI 360 for the implementation of Act to End Neglected Tropical Disease West (Act | West) program from July 19, 2018–July 18, 2023. The program is part of the global effort to eliminate neglected tropical diseases (NTDs). It particularly aims to eliminate lymphatic filariasis (LF), trachoma, and onchocerciasis (OV) (in certain countries) and control schistosomiasis (SCH) and soil-transmitted helminthiasis (STH) in 11 endemic West African countries—including Burkina Faso, Benin, Cameroon, Guinea, Ghana, Côte D’Ivoire, Mali, Niger, Senegal, Sierra Leone, and Togo. It also supports achievement of sustainable service delivery, with growing ownership of national governments in the elimination and/or control of NTDs. This report outlines the key achievements and challenges in the first six months of the second year of program implementation, spanning the period April 1, 2020–September 30, 2020.
Trachoma baseline surveys, trachoma impact surveys, trachoma surveillance surveys, and trichiasis-only surveys are key disease-specific assessments of trachoma elimination programs, used to start mass drug administration (MDA), monitor progress, decide when to stop MDA, and inform attainment of elimination of trachoma as a public health problem.
This report outlines the key achievements and challenges in the first six months of the second year of implementation of USAID's Act to End NTDs | West Program, spanning the period October 1, 2019–March 31, 2020.